Quadrant Capital Group LLC Mesoblast LTD Transaction History

Quadrant Capital Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.22 - $4.83 $10,330 - $40,900	-8,468 Reduced 72.35%	3,236 $3,000
Q2 2023 Aug 09, 2023	BUY	$2.95 - $4.44 $14,894 - $22,417	5,049 Added 75.87%	11,704 $45,000
Q1 2023 May 11, 2023	BUY	$2.94 - $4.18 $291 - $413	99 Added 1.51%	6,655 $21,000
Q4 2022 Feb 10, 2023	BUY	$2.73 - $3.7 $15,457 - $20,949	5,662 Added 633.33%	6,556 $19,000
Q3 2022 Nov 10, 2022	SELL	$0.48 - $3.48 $722 - $5,237	-1,505 Reduced 62.73%	894 $2,000
Q2 2022 Aug 09, 2022	BUY	$2.22 - $4.54 $3,964 - $8,108	1,786 Added 291.35%	2,399 $5,000
Q1 2022 May 06, 2022	BUY	$3.58 - $4.98 $1,843 - $2,564	515 Added 525.51%	613 $3,000
Q4 2021 Feb 01, 2022	SELL	$4.17 - $7.09 $1,084 - $1,843	-260 Reduced 72.63%	98 $0
Q3 2021 Nov 12, 2021	SELL	$5.87 - $7.85 $8,247 - $11,029	-1,405 Reduced 79.69%	358 $2,000
Q2 2021 Aug 09, 2021	BUY	$6.69 - $9.0 $11,419 - $15,363	1,707 Added 3048.21%	1,763 $13,000
Q1 2021 May 12, 2021	BUY	$8.26 - $11.4 $462 - $638	56 New	56 $0

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.